van Roon-Mom W - Search Results

1

A 3 months mild functional test regime does not affect disease parameters in young mdx mice.

van Putten M, de Winter C, van Roon-Mom W, van Ommen GJ, 't Hoen PA, Aartsma-Rus A. van Putten M, et al. Neuromuscul Disord. 2010 Apr;20(4):273-80. doi: 10.1016/j.nmd.2010.02.004. Epub 2010 Mar 21. Neuromuscul Disord. 2010. PMID: 20307983

2

Mutant huntingtin activates Nrf2-responsive genes and impairs dopamine synthesis in a PC12 model of Huntington's disease.

van Roon-Mom WM, Pepers BA, 't Hoen PA, Verwijmeren CA, den Dunnen JT, Dorsman JC, van Ommen GB. van Roon-Mom WM, et al. BMC Mol Biol. 2008 Oct 9;9:84. doi: 10.1186/1471-2199-9-84. BMC Mol Biol. 2008. PMID: 18844975 Free PMC article.

3

Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease.

Aziz NA, Jurgens CK, Landwehrmeyer GB; EHDN Registry Study Group; van Roon-Mom WM, van Ommen GJ, Stijnen T, Roos RA. Aziz NA, et al. Neurology. 2009 Oct 20;73(16):1280-5. doi: 10.1212/WNL.0b013e3181bd1121. Epub 2009 Sep 23. Neurology. 2009. PMID: 19776381

4

In silico discovery and experimental validation of new protein-protein interactions.

van Haagen HH, 't Hoen PA, de Morrée A, van Roon-Mom WM, Peters DJ, Roos M, Mons B, van Ommen GJ, Schuemie MJ. van Haagen HH, et al. Proteomics. 2011 Mar;11(5):843-53. doi: 10.1002/pmic.201000398. Epub 2011 Jan 31. Proteomics. 2011. PMID: 21280221

5

Antisense-mediated RNA targeting: versatile and expedient genetic manipulation in the brain.

Zalachoras I, Evers MM, van Roon-Mom WM, Aartsma-Rus AM, Meijer OC. Zalachoras I, et al. Front Mol Neurosci. 2011 Jul 19;4:10. doi: 10.3389/fnmol.2011.00010. eCollection 2011. Front Mol Neurosci. 2011. PMID: 21811437 Free PMC article.

6

Targeting several CAG expansion diseases by a single antisense oligonucleotide.

Evers MM, Pepers BA, van Deutekom JC, Mulders SA, den Dunnen JT, Aartsma-Rus A, van Ommen GJ, van Roon-Mom WM. Evers MM, et al. PLoS One. 2011;6(9):e24308. doi: 10.1371/journal.pone.0024308. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21909428 Free PMC article.

7

Increased sensitivity of next generation sequencing-based expression profiling after globin reduction in human blood RNA.

Mastrokolias A, den Dunnen JT, van Ommen GB, 't Hoen PA, van Roon-Mom WM. Mastrokolias A, et al. BMC Genomics. 2012 Jan 18;13:28. doi: 10.1186/1471-2164-13-28. BMC Genomics. 2012. PMID: 22257641 Free PMC article.

8

Overview on applications of antisense-mediated exon skipping.

van Roon-Mom WM, Aartsma-Rus A. van Roon-Mom WM, et al. Methods Mol Biol. 2012;867:79-96. doi: 10.1007/978-1-61779-767-5_6. Methods Mol Biol. 2012. PMID: 22454056 Review.

9

Exploring the transcriptome of ciliated cells using in silico dissection of human tissues.

Ivliev AE, 't Hoen PA, van Roon-Mom WM, Peters DJ, Sergeeva MG. Ivliev AE, et al. PLoS One. 2012;7(4):e35618. doi: 10.1371/journal.pone.0035618. Epub 2012 Apr 25. PLoS One. 2012. PMID: 22558177 Free PMC article.

10

Antisense-mediated isoform switching of steroid receptor coactivator-1 in the central nucleus of the amygdala of the mouse brain.

Zalachoras I, Grootaers G, van Weert LT, Aubert Y, de Kreij SR, Datson NA, van Roon-Mom WM, Aartsma-Rus A, Meijer OC. Zalachoras I, et al. BMC Neurosci. 2013 Jan 7;14:5. doi: 10.1186/1471-2202-14-5. BMC Neurosci. 2013. PMID: 23294837 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

105 results

Search Page

Filters